DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Depocyt (Cytarabine) - Hepatic Enzyme Increased - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Hepatic Enzyme Increased (6)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Depocyt (Cytarabine) where reactions include hepatic enzyme increased. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Depocyt side effects in 20 year old male

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-04-02

Patient: 20 year old male

Reactions: Pneumocystis Jiroveci Pneumonia, Mucosal Inflammation, Herpes Simplex, Hyperkalaemia, Febrile Bone Marrow Aplasia, Hepatic Enzyme Increased

Drug(s) suspected as cause:
Doxorubicin HCL

Doxorubicin HCL

Dexamethasone

Depocyt
    Indication: Burkitt's Lymphoma

Dexamethasone

Cytarabine

Doxorubicin HCL
    Indication: Burkitt's Lymphoma

Vincristine

Methotrexate
    Indication: Burkitt's Lymphoma

Rituximab
    Dosage: day 1
    Indication: Burkitt's Lymphoma

Doxorubicin HCL

Doxorubicin HCL

Cyclophosphamide

Methotrexate

Cytarabine
    Indication: Burkitt's Lymphoma

Doxorubicin HCL

Doxorubicin HCL

Vincristine

Methotrexate

Prednisone TAB
    Indication: Burkitt's Lymphoma

Dexamethasone
    Indication: Burkitt's Lymphoma

Cytarabine

Cyclophosphamide
    Dosage: a1-a3

Cyclophosphamide

Vincristine
    Indication: Burkitt's Lymphoma

Vincristine

Doxorubicin HCL

Cyclophosphamide
    Indication: Burkitt's Lymphoma

Cyclophosphamide

Dexamethasone

Methotrexate

Cytarabine



Possible Depocyt side effects in 63 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-09

Patient: 63 year old female

Reactions: Death, Vomiting, Neoplasm Malignant, Nausea, Diarrhoea, Hepatic Enzyme Increased

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Depocyt
    Dosage: 6sep11,20sep11
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-08-23
    End date: 2011-09-20

Sprycel
    Dosage: stoppd on 6sep10 and restartd on oct2011-death(13 month)
    Administration route: Oral
    Indication: Chronic Myeloid Leukaemia
    Start date: 2010-06-05



Possible Depocyt side effects in 20 year old male

Reported by a individual with unspecified qualification from Germany on 2011-12-16

Patient: 20 year old male

Reactions: Mucosal Inflammation, Pneumocystis Jiroveci Pneumonia, Hyperkalaemia, Herpes Simplex, Bone Marrow Failure, Hepatic Enzyme Increased

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 300 mg abs. in a1-a3

Cyclophosphamide
    Indication: Burkitt's Lymphoma

Doxorubicin HCL
    Indication: Burkitt's Lymphoma

Depocyt
    Indication: Burkitt's Lymphoma

Vincristine
    Indication: Burkitt's Lymphoma

Dexamethasone
    Indication: Burkitt's Lymphoma

Rituximab
    Indication: Burkitt's Lymphoma



Possible Depocyt side effects in 20 year old male

Reported by a health professional (non-physician/pharmacist) from Germany on 2011-12-08

Patient: 20 year old male

Reactions: Mucosal Inflammation, Pneumocystis Jiroveci Pneumonia, Herpes Simplex, Hyperkalaemia, Aplasia, Hepatic Enzyme Increased

Drug(s) suspected as cause:
Doxorubicin HCL
    Indication: Burkitt's Lymphoma

Dexamethasone
    Indication: Burkitt's Lymphoma

Rituximab
    Indication: Burkitt's Lymphoma

Vincristine
    Indication: Burkitt's Lymphoma

Cyclophosphamide
    Indication: Burkitt's Lymphoma

Depocyt
    Indication: Burkitt's Lymphoma

Cyclophosphamide
    Dosage: 300 mg abs. in a1-a3



Possible Depocyt side effects in 20 year old male

Reported by a health professional (non-physician/pharmacist) from Germany on 2011-11-23

Patient: 20 year old male

Reactions: Mucosal Inflammation, Pneumocystis Jiroveci Pneumonia, Hyperkalaemia, Herpes Simplex, Febrile Bone Marrow Aplasia, Hepatic Enzyme Increased

Drug(s) suspected as cause:
Cyclophosphamide

Dexamethasone
    Indication: Burkitt's Lymphoma

Doxorubicin HCL

Dexamethasone

Doxorubicin HCL

Vincristine
    Indication: Burkitt's Lymphoma

Vincristine

Methotrexate
    Indication: Burkitt's Lymphoma

Methotrexate

Cyclophosphamide
    Indication: Burkitt's Lymphoma

Cyclophosphamide
    Dosage: a1-a3

Doxorubicin HCL

Cyclophosphamide

Cyclophosphamide

Dexamethasone

Methotrexate

Methotrexate

Cytarabine
    Indication: Burkitt's Lymphoma

Prednisone TAB
    Indication: Burkitt's Lymphoma

Doxorubicin HCL
    Indication: Burkitt's Lymphoma

Vincristine

Cytarabine

Cytarabine

Vincristine

Dexamethasone

Cytarabine

Rituximab
    Dosage: day 1
    Indication: Burkitt's Lymphoma

Depocyt
    Indication: Burkitt's Lymphoma



Possible Depocyt side effects in 20 year old male

Reported by a health professional (non-physician/pharmacist) from Germany on 2011-11-23

Patient: 20 year old male

Reactions: Pneumocystis Jiroveci Pneumonia, Mucosal Inflammation, Hyperkalaemia, Herpes Simplex, Febrile Bone Marrow Aplasia, Hepatic Enzyme Increased

Drug(s) suspected as cause:
Doxorubicin HCL
    Indication: Burkitt's Lymphoma

Cyclophosphamide
    Indication: Burkitt's Lymphoma

Methotrexate
    Indication: Burkitt's Lymphoma

Cytarabine

Dexamethasone
    Indication: Burkitt's Lymphoma

Methotrexate

Cytarabine

Doxorubicin HCL

Cytarabine
    Indication: Burkitt's Lymphoma

Rituximab
    Dosage: day 1
    Indication: Burkitt's Lymphoma

Doxorubicin HCL

Dexamethasone

Prednisone TAB
    Indication: Burkitt's Lymphoma

Cyclophosphamide

Dexamethasone

Cytarabine

Cyclophosphamide

Cyclophosphamide
    Dosage: a1-a3

Vincristine

Vincristine

Depocyt
    Indication: Burkitt's Lymphoma

Doxorubicin HCL

Methotrexate

Cyclophosphamide

Vincristine
    Indication: Burkitt's Lymphoma

Vincristine

Dexamethasone

Methotrexate

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017